https://www.scirp.org/journal/PaperInformation?paperID=29922&
Discover a promising treatment option for recurrent malignant GBM of the brain. Learn about a case study with long-term remission after post-surgical FTM...
complete remissionlong termsurvivalrecurrentmalignant
https://www.prnewswire.com/news-releases/ariceum-therapeutics-commences-phase-1-clinical-trial-in-patients-with-recurrent-glioblastoma-302205348.html
/PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain...
clinical trialtherapeuticsphasepatients
https://pubmed.ncbi.nlm.nih.gov/27270908/
IDH1 mutated glioblastoma (GB) has a better prognosis than IDH1 wildtype GB. However, it remains unknown whether patients (pts) with IDH1 mutated GB have a...
clinical trialsimpactmutationstatusoutcome
https://www.pharmaceutical-technology.com/data-insights/recurrent-glioblastoma-multiforme-gbm-drugs-in-development/
GlobalData tracks 161 drugs in development for Recurrent Glioblastoma Multiforme (GBM) by 141 companies/universities/institutes. The top development phase for...
recurrent glioblastomamultiformegbmdrugsdevelopment